These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 33791166)

  • 1. Impact of
    Schneeweiss-Gleixner M; Greiner G; Herndlhofer S; Schellnegger J; Krauth MT; Gleixner KV; Wimazal F; Steinhauser C; Kundi M; Thalhammer R; Schwarzinger I; Hoermann G; Esterbauer H; Födinger M; Valent P; Sperr WR
    Am J Cancer Res; 2021; 11(3):955-967. PubMed ID: 33791166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Study on HFE gene mutations in patients with myelodysplastic syndromes and aplastic anemia].
    Nie L; Ai XF; Zheng YZ; Li QH; Yang L; Xiao ZJ
    Zhonghua Xue Ye Xue Za Zhi; 2009 Apr; 30(4):223-8. PubMed ID: 19731820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemochromatosis-associated gene mutations in patients with myelodysplastic syndromes with refractory anemia with ringed sideroblasts.
    Nearman ZP; Szpurka H; Serio B; Warshawksy I; Theil K; Lichtin A; Sekeres MA; Maciejewski JP
    Am J Hematol; 2007 Dec; 82(12):1076-9. PubMed ID: 17654685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High incidence of hemochromatosis gene mutations in the myelodysplastic syndrome: the Budapest Study on 50 patients.
    Várkonyi J; Tarkovács G; Karádi I; Andrikovics H; Varga F; Varga F; Demeter J; Tordai A
    Acta Haematol; 2003; 109(2):64-7. PubMed ID: 12624489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemochromatosis gene mutations may affect the survival of patients with myelodysplastic syndrome.
    Lucijanić M; Pejša V; Mitrović Z; Štoos-Veić T; Livun A; Jakšić O; Vasilj T; Piršić M; Hariš V; Prka Ž; Kušec R
    Hematology; 2016 Apr; 21(3):170-4. PubMed ID: 27077775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HFE gene mutation and oxidative damage biomarkers in patients with myelodysplastic syndromes and its relation to transfusional iron overload: an observational cross-sectional study.
    De Souza GF; Ribeiro HL; De Sousa JC; Heredia FF; De Freitas RM; Martins MR; Gonçalves RP; Pinheiro RF; Magalhães SM
    BMJ Open; 2015 Apr; 5(4):e006048. PubMed ID: 25841232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mild iron overload in patients carrying the HFE S65C gene mutation: a retrospective study in patients with suspected iron overload and healthy controls.
    Holmström P; Marmur J; Eggertsen G; Gåfvels M; Stål P
    Gut; 2002 Nov; 51(5):723-30. PubMed ID: 12377814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic screening for HFE hemochromatosis in 6,020 Danish men: penetrance of C282Y, H63D, and S65C variants.
    Pedersen P; Milman N
    Ann Hematol; 2009 Aug; 88(8):775-84. PubMed ID: 19159930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Mutations in the HFE gene (C282Y, H63D, S65C) in alcoholic patients with finding of iron overload].
    Campos Franco J; González Quintela A; Fernández de Trocóniz LL; Barros Angueira F; Pérez-Quintela BV; Pérez Becerra E; Martínez de Rituerto ST; Otero Antón E; Torre Carballada JA
    Rev Clin Esp; 2002 Oct; 202(10):534-9. PubMed ID: 12361551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of HFE gene mutations and HLA-A alleles in Brazilian patients with iron overload.
    Cançado RD; Guglielmi AC; Vergueiro CS; Rolim EG; Figueiredo MS; Chiattone CS
    Sao Paulo Med J; 2006 Mar; 124(2):55-60. PubMed ID: 16878186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HFE mutations, iron deficiency and overload in 10,500 blood donors.
    Jackson HA; Carter K; Darke C; Guttridge MG; Ravine D; Hutton RD; Napier JA; Worwood M
    Br J Haematol; 2001 Aug; 114(2):474-84. PubMed ID: 11529872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iron-overload and genotypic expression of HFE mutations H63D/C282Y and transferrin receptor Hin6I and BanI polymorphism in german patients with hereditary haemochromatosis.
    Gottschalk R; Seidl C; Schilling S; Braner A; Seifried E; Hoelzer D; Kaltwasser JP
    Eur J Immunogenet; 2000 Jun; 27(3):129-34. PubMed ID: 10940080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum tryptase measurements in patients with myelodysplastic syndromes.
    Sperr WR; Stehberger B; Wimazal F; Baghestanian M; Schwartz LB; Kundi M; Semper H; Jordan JH; Chott A; Drach J; Jäger U; Geissler K; Greschniok A; Horny HP; Lechner K; Valent P
    Leuk Lymphoma; 2002 May; 43(5):1097-105. PubMed ID: 12148892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of HFE mutations among the Thai population and correlation with iron loading in haemoglobin E disorder.
    Viprakasit V; Vathesathokit P; Chinchang W; Tachavanich K; Pung-Amritt P; Wimhurst VL; Yenchitsomanus PT; Merryweather-Clarke AT; Tanphaichitr VS
    Eur J Haematol; 2004 Jul; 73(1):43-9. PubMed ID: 15182337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of HFE mutations (C282Y and H63D) with iron overload in blood donors from Mexico City.
    Baptista-González HA; Rosenfeld-Mann F; Trueba-Gómez R; Bermejo-Martínez L; Méndez-Sánchez N
    Ann Hepatol; 2007; 6(1):55-60. PubMed ID: 17297430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extrinsic factors modifying expressivity of the HFE variant C282Y, H63D, S65C phenotypes in 1,294 Danish men.
    Pedersen P; Milman N
    Ann Hematol; 2009 Oct; 88(10):957-65. PubMed ID: 19271219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of transfusional iron overload in patients with myelodysplastic syndrome or severe anemia: data from multicenter clinical practices.
    Raptis A; Duh MS; Wang ST; Dial E; Fanourgiakis I; Fortner B; Paley C; Mody-Patel N; Corral M; Scott J
    Transfusion; 2010 Jan; 50(1):190-9. PubMed ID: 19719471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequency of Hereditary Hemochromatosis (HFE) Gene Mutations in Egyptian Beta Thalassemia Patients and its Relation to Iron Overload.
    Enein AA; El Dessouky NA; Mohamed KS; Botros SK; Abd El Gawad MF; Hamdy M; Dyaa N
    Open Access Maced J Med Sci; 2016 Jun; 4(2):226-31. PubMed ID: 27335591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Myelodysplastic syndromes (MDS). Aspects of hematopathologic diagnosis].
    Schmitt-Graeff A; Mattern D; Köhler H; Hezel J; Lübbert M
    Pathologe; 2000 Jan; 21(1):1-15. PubMed ID: 10663664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myelodysplastic syndromes. A clinical and pathologic analysis of 109 cases.
    Foucar K; Langdon RM; Armitage JO; Olson DB; Carroll TJ
    Cancer; 1985 Aug; 56(3):553-61. PubMed ID: 3891071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.